Equities

Medartis Holding AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Medartis Holding AG

Actions
  • Price (CHF)89.10
  • Today's Change-0.90 / -1.00%
  • Shares traded676.00
  • 1 Year change+29.88%
  • Beta1.6667
Data delayed at least 15 minutes, as of Feb 11 2026 11:07 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

  • Revenue in CHF (TTM)236.34m
  • Net income in CHF-487.00k
  • Incorporated1997
  • Employees1.16k
  • Location
    Medartis Holding AGHochbergerstrasse 60EBASEL 4057SwitzerlandCHE
  • Phone+41 616333434
  • Fax+41 616333400
  • Websitehttps://www.medartis.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MED:SWX since
announced
Transaction
value
Kerimedical SAAnnounced17 Jul 202517 Jul 2025Announced14.23%123.70m
Neoortho Produtos Ortopedicos SaAnnounced18 Mar 202518 Mar 2025Announced26.38%--
Data delayed at least 15 minutes, as of Feb 11 2026 11:07 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
COLTENE Holding AG240.71m14.31m333.44m1.18k23.303.6915.831.392.402.4040.2215.131.311.346.40204,684.507.8010.5914.2618.4366.1162.195.957.640.70437.620.360685.663.06-1.7971.310.4306-15.4510.76
IVF Hartmann Holding AG159.45m19.02m346.80m309.0018.252.3914.332.187.927.9266.3960.570.89643.287.88526,221.1010.697.9012.919.6855.7154.0611.939.133.79--0.004248.547.332.8534.0210.78-28.9419.92
medmix AG468.10m-5.80m493.50m2.67k--1.1510.131.05-0.1696-0.169611.6010.390.47073.565.86174,403.90-0.49271.27-0.61991.5534.5235.24-1.052.651.101.870.4268140.79-0.55492.84-2,566.67--6.02--
Medartis Holding AG236.34m-487.00k1.23bn1.16k--4.2853.855.19-0.0344-0.034420.2521.030.50820.59865.33249,045.30-0.08280.2609-0.09530.294579.1181.17-0.16290.46953.572.110.32340.006.0511.55469.9510.45-10.60--
SKAN Group AG332.13m16.18m1.26bn1.50k77.707.0942.123.780.71950.719514.777.880.90520.70915.33241,201.204.867.699.2816.0374.3872.975.378.890.52416.870.051828.0912.9080.5147.4716.66----
Medacta Group SA590.08m86.71m3.08bn2.04k35.457.9220.495.224.344.3429.5619.440.81130.8535.83309,429.8011.929.0715.2911.8467.5569.3114.6911.570.947210.510.375118.6815.6213.7153.8943.7915.22--
Ypsomed Holding AG787.55m194.00m4.11bn2.00k21.185.0915.035.2214.2114.2157.7059.140.65916.145.78297,862.7016.245.5523.888.6741.2532.3224.639.241.1927.750.119919.7836.5413.6911.6649.4618.4861.54
Data as of Feb 11 2026. Currency figures normalised to Medartis Holding AG's reporting currency: Swiss Franc CHF

Institutional shareholders

19.72%Per cent of shares held by top holders
HolderShares% Held
Nordflint Capital Partners Fondsm�glerselskab A/Sas of 23 Sep 20251.36m9.97%
Vontobel Asset Management AGas of 31 Dec 2025422.81k3.10%
Pictet Asset Management SAas of 31 Oct 2025337.55k2.48%
UBS Asset Management Switzerland AGas of 06 Jan 2026180.26k1.32%
The Vanguard Group, Inc.as of 07 Jan 2026170.27k1.25%
Deka Investment GmbHas of 30 Sep 202563.82k0.47%
Z�rcher Kantonalbank (Investment Management)as of 31 Dec 202562.99k0.46%
BlackRock Investment Management (UK) Ltd.as of 30 Nov 202539.58k0.29%
Swiss KMU Partners AGas of 31 Dec 202526.00k0.19%
Banque Cantonale Vaudoise (Investment Management)as of 30 Sep 202525.23k0.19%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.